These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 11857318)

  • 1. Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.
    Shen B; Ormsby AH; Shen C; Dumot JA; Shao YW; Bevins CL; Gramlich TL
    Cancer; 2002 Feb; 94(3):820-31. PubMed ID: 11857318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.
    Jovanovic I; Tzardi M; Mouzas IA; Micev M; Pesko P; Milosavljevic T; Zois M; Sganzos M; Delides G; Kanavaros P
    Histol Histopathol; 2002 Apr; 17(2):445-54. PubMed ID: 11962749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.
    Ormsby AH; Goldblum JR; Rice TW; Richter JE; Falk GW; Vaezi MF; Gramlich TL
    Hum Pathol; 1999 Mar; 30(3):288-94. PubMed ID: 10088547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.
    Mohammed IA; Streutker CJ; Riddell RH
    Mod Pathol; 2002 Jun; 15(6):611-6. PubMed ID: 12065774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology.
    Couvelard A; Cauvin JM; Goldfain D; Rotenberg A; Robaszkiewicz M; Fléjou JF;
    Gut; 2001 Dec; 49(6):761-6. PubMed ID: 11709508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin 7/20 and MUC1, 2, 5AC, and 6 expression patterns in Barrett's esophagus and intestinal metaplasia of the stomach: intestinal metaplasia of the cardia is related to Barrett's esophagus.
    Gulmann C; Shaqaqi OA; Grace A; Leader M; Patchett S; Butler D; Kay E
    Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):142-7. PubMed ID: 15354740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interinstitutional variability and effect of tissue fixative on the interpretation of a Barrett cytokeratin 7/20 immunoreactivity pattern in Barrett esophagus.
    Glickman JN; Ormsby AH; Gramlich TL; Goldblum JR; Odze RD
    Hum Pathol; 2005 Jan; 36(1):58-65. PubMed ID: 15712183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors.
    Mattioli S; Ruffato A; Di Simone MP; Corti B; D'Errico A; Lugaresi ML; Mattioli B; D'Ovidio F
    Ann Thorac Surg; 2007 May; 83(5):1814-9. PubMed ID: 17462405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus.
    Ormsby AH; Vaezi MF; Richter JE; Goldblum JR; Rice TW; Falk GW; Gramlich TL
    Gastroenterology; 2000 Sep; 119(3):683-90. PubMed ID: 10982762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI.
    Glickman JN; Wang H; Das KM; Goyal RK; Spechler SJ; Antonioli D; Odze RD
    Am J Surg Pathol; 2001 Jan; 25(1):87-94. PubMed ID: 11145256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma.
    Ormsby AH; Goldblum JR; Rice TW; Richter JE; Gramlich TL
    Histopathology; 2001 Apr; 38(4):307-11. PubMed ID: 11318895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.
    Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
    World J Gastroenterol; 2005 Oct; 11(40):6360-5. PubMed ID: 16419166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
    Kurtkaya-Yapicier O; Gencosmanoglu R; Avsar E; Bakirci N; Tozun N; Sav A
    BMC Clin Pathol; 2003 Dec; 3(1):5. PubMed ID: 14651756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.
    Flucke U; Steinborn E; Dries V; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.
    DeMeester SR; Wickramasinghe KS; Lord RV; Friedman A; Balaji NS; Chandrasoma PT; Hagen JA; Peters JH; DeMeester TR
    Am J Gastroenterol; 2002 Oct; 97(10):2514-23. PubMed ID: 12385432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Barrett's esophagus with CK7, CK20, p53, Ki67, and COX2 expressions using chromoendoscopical examination.
    Çoban Ş; Örmeci N; Savaş B; Ekiz F; Ensari A; Kuzu I; Palabıyıkoğlu M
    Dis Esophagus; 2013; 26(2):189-96. PubMed ID: 22591041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytokeratin 7 and 20 in Barrett's esophagus].
    Arra A; Nieva NB; Rey N; Fernández AO
    Rev Fac Cien Med Univ Nac Cordoba; 2005; 62(3):57-62. PubMed ID: 16972735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
    J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's esophagus and cardiac intestinal metaplasia: two conditions within the same spectrum.
    White NM; Gabril M; Ejeckam G; Mathews M; Fardy J; Kamel F; Doré J; Yousef GM
    Can J Gastroenterol; 2008 Apr; 22(4):369-75. PubMed ID: 18414711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.